Literature DB >> 31004195

Development of a standard set of outcome measures for non-specific low back pain in Dutch primary care physiotherapy practices: a Delphi study.

A C Verburg1, S A van Dulmen2, H Kiers3,4, M W G Nijhuis-van der Sanden2, P J van der Wees2.   

Abstract

PURPOSE: To develop a clinical standard set of outcome measures that are accepted for relevance and feasibility by stakeholders and useful for (a) interaction between patient and the professional, e.g. shared decision-making in goal-setting, monitoring and feedback based on outcomes, (b) internal quality improvement, and (c) external transparency in patients with non-specific low back pain (NSLBP) in primary care physical therapy.
METHODS: We used a consensus-driven modified RAND-UCLA Delphi method in seven steps with panellists (patients, representatives of patient and physiotherapy associations, researchers, policy makers, health insurers): (1) literature search, (2) first online survey, (3) patient interviews, (4) an experts meeting, (5) a consensus meeting, (6) second online survey, and (7) final approval of an advisory board. Steps 1-4 resulted in potential outcome measures. In the consensus meeting after discussion panellists voted for inclusion per measure. In the second online survey the final standard set was rated on relevance and feasibility on a 9-point Likert scale; when the median score was ≥ 7, the standard set was accepted and finally approved.
RESULTS: Thirteen draft outcome measures were rated and discussed, and finally, six outcome measures were accepted. The standard set includes the Quebec Back Pain Disability Scale, Oswestry Disability Index, Patient-Specific Functional Scale, Numeric Pain Rating Scale, Global Perceived Effect (GPE-DV), and the STarT Back Screening Tool (SBT).
CONCLUSION: This study presents a standard set of outcome measures for patients with NSLBP in primary care physiotherapy accepted for relevance and feasibility by stakeholders. The standard set is currently used in daily practice and tested on validity and reliability in a pilot study. These slides can be retrieved under Electronic Supplementary Material.

Entities:  

Keywords:  Delphi; Non-specific low back pain; Outcome measures; PREMs; PROMs

Year:  2019        PMID: 31004195     DOI: 10.1007/s00586-019-05962-x

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  49 in total

1.  Using the 0-to-10 pain rating scale.

Authors:  M McCaffery
Journal:  Am J Nurs       Date:  2001-10       Impact factor: 2.220

2.  Medscape's response to the Institute of Medicine Report: Crossing the quality chasm: a new health system for the 21st century.

Authors:  M Leavitt
Journal:  MedGenMed       Date:  2001-03-05

Review 3.  Research methods used in developing and applying quality indicators in primary care.

Authors:  S M Campbell; J Braspenning; A Hutchinson; M N Marshall
Journal:  BMJ       Date:  2003-04-12

4.  A patient-specific approach for measuring functional status in low back pain.

Authors:  A J Beurskens; H C de Vet; A J Köke; E Lindeman; G J van der Heijden; W Regtop; P G Knipschild
Journal:  J Manipulative Physiol Ther       Date:  1999 Mar-Apr       Impact factor: 1.437

5.  Subgroups within "nonspecific" low back pain.

Authors:  Gordon Waddell
Journal:  J Rheumatol       Date:  2005-03       Impact factor: 4.666

6.  Chapter 2. European guidelines for prevention in low back pain : November 2004.

Authors:  A K Burton; F Balagué; G Cardon; H R Eriksen; Y Henrotin; A Lahad; A Leclerc; G Müller; A J van der Beek
Journal:  Eur Spine J       Date:  2006-03       Impact factor: 3.134

7.  Chapter 4. European guidelines for the management of chronic nonspecific low back pain.

Authors:  O Airaksinen; J I Brox; C Cedraschi; J Hildebrandt; J Klaber-Moffett; F Kovacs; A F Mannion; S Reis; J B Staal; H Ursin; G Zanoli
Journal:  Eur Spine J       Date:  2006-03       Impact factor: 3.134

8.  Chapter 3. European guidelines for the management of acute nonspecific low back pain in primary care.

Authors:  Maurits van Tulder; Annette Becker; Trudy Bekkering; Alan Breen; Maria Teresa Gil del Real; Allen Hutchinson; Bart Koes; Even Laerum; Antti Malmivaara
Journal:  Eur Spine J       Date:  2006-03       Impact factor: 3.134

Review 9.  Outcome assessments in the evaluation of treatment of spinal disorders: summary and general recommendations.

Authors:  C Bombardier
Journal:  Spine (Phila Pa 1976)       Date:  2000-12-15       Impact factor: 3.468

Review 10.  The characteristics of patient satisfaction measures.

Authors:  P L Hudak; J G Wright
Journal:  Spine (Phila Pa 1976)       Date:  2000-12-15       Impact factor: 3.468

View more
  4 in total

1.  Clinical Characteristics and Patient-Reported Outcomes of Primary Care Physiotherapy in Patients with Whiplash-Associated Disorders: A Longitudinal Observational Study.

Authors:  Rob A B Oostendorp; J W Hans Elvers; Emiel van Trijffel; Geert M Rutten; Gwendolyne G M Scholten-Peeters; Marcel Heijmans; Erik Hendriks; Emilia Mikolajewska; Margot De Kooning; Marjan Laekeman; Jo Nijs; Nathalie Roussel; Han Samwel
Journal:  Patient Prefer Adherence       Date:  2020-09-28       Impact factor: 2.711

2.  Developing key performance indicators for the Canadian chiropractic profession: a modified Delphi study.

Authors:  Marc-André Blanchette; Silvano Mior; Shawn Thistle; Kent Stuber
Journal:  Chiropr Man Therap       Date:  2022-08-01

3.  Improved quality of physiotherapy care in patients with Whiplash-Associated Disorders: Results based on 16 years of routinely collected data.

Authors:  Rob A B Oostendorp; Hans Elvers; Emiel van Trijffel; Geert M Rutten; Gwendolyne G M Scholten-Peeters; Margot De Kooning; Marjan Laekeman; Jo Nijs; Nathalie Roussel; Han Samwel
Journal:  Front Pain Res (Lausanne)       Date:  2022-08-30

4.  Use and perceived added value of patient-reported measurement instruments by physiotherapists treating acute low back pain: a survey study among Dutch physiotherapists.

Authors:  J Knoop; W van Lankveld; F J B Geerdink; R Soer; J B Staal
Journal:  BMC Musculoskelet Disord       Date:  2020-02-24       Impact factor: 2.362

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.